Tokai Pharmaceuticals Inc. (TKAI) Stock Price, Quote, News and Overview
NASDAQ:TKAI - Nasdaq -
TKAI Quote, Performance and Key Statistics
0.61
-0.03 (-4.69%)
The current stock price of TKAI is 0.61 null. In the past month the price decreased by -7.58%. In the past year, price decreased by -91.16%.
About TKAI
Company Profile
Tokai Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for prostate cancer and other hormonally-driven diseases. The Company's lead drug candidate includes galeterone, an oral small molecule drug candidate, which is in Phase II clinical trials for the treatment of castration resistant prostate cancer. Tokai Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.
Company Info
Tokai Pharmaceuticals Inc.
255 STATE STREET 6TH FLOOR
BOSTON MA 02109
CEO: Jodie P. Morrison
Phone: 617-225-4305
Tokai Pharmaceuticals Inc. / TKAI FAQ
What is the stock price of Tokai Pharmaceuticals Inc. today?
The current stock price of TKAI is 0.61 null. The price decreased by -4.69% in the last trading session.
What is the ticker symbol for Tokai Pharmaceuticals Inc. stock?
The exchange symbol of Tokai Pharmaceuticals Inc. is TKAI and it is listed on the Nasdaq exchange.
On which exchange is TKAI stock listed?
TKAI stock is listed on the Nasdaq exchange.
What is Tokai Pharmaceuticals Inc. worth?
Tokai Pharmaceuticals Inc. (TKAI) has a market capitalization of 13.81M null. This makes TKAI a Nano Cap stock.
What are the support and resistance levels for Tokai Pharmaceuticals Inc. (TKAI) stock?
Tokai Pharmaceuticals Inc. (TKAI) has a resistance level at 0.65. Check the full technical report for a detailed analysis of TKAI support and resistance levels.
Should I buy Tokai Pharmaceuticals Inc. (TKAI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TKAI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TKAI, evaluating the profitability, health, valuation and growth aspects
- Tokai Pharmaceuticals Inc. (TKAI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Tokai Pharmaceuticals Inc. (TKAI) Sales and EPS estimates to see what analysts future expectations are.
- Tokai Pharmaceuticals Inc. (TKAI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Tokai Pharmaceuticals Inc. (TKAI) Insider and Institutional Ownership to learn about the owners and their transactions.
- Tokai Pharmaceuticals Inc. (TKAI) Stock Chart to make your own analysis
- Tokai Pharmaceuticals Inc. (TKAI) Latest news and press-releases to stay up to date.
Does Tokai Pharmaceuticals Inc. (TKAI) stock pay dividends?
TKAI does not pay a dividend.
What is the Price/Earnings (PE) ratio of Tokai Pharmaceuticals Inc. (TKAI)?
Tokai Pharmaceuticals Inc. (TKAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.01).
TKAI Technical Analysis
TKAI Financial Highlights
Over the last trailing twelve months TKAI reported a non-GAAP Earnings per Share(EPS) of -2.01. The EPS increased by 59.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.27% | ||
| ROA | -87.37% | ||
| ROE | -101.88% | ||
| Debt/Equity | 0 |